PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Despite the significant achievements in the diagnosis and treatment of metastatic breast cancer (MBC), this condition remains substantially an incurable disease. In recent years, several clinical studies have aimed to identify novel molecular targets, therapeutic strategies, and predictive biomarker...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Fusco, Nicola, Malapelle, Umberto, Fassan, Matteo, Marchiò, Caterina, Buglioni, Simonetta, Zupo, Simonetta, Criscitiello, Carmen, Vigneri, Paolo, Dei Tos, Angelo Paolo, Maiorano, Eugenio, Viale, Giuseppe
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027489/
https://ncbi.nlm.nih.gov/pubmed/33842357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.644737
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires